Gabrielle Leclercq-Cohen
7PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 22, 2026
Molecular features of response and resistance to glofitamab, a T-cell engager for treatment of large B-cell lymphoma.Stephan Schmeing, Sina Nassiri, Gabrielle Leclercq-Cohen
|Aug 01, 2025
Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma.Johannes Sam, Gabrielle Leclercq-Cohen, Samuel Gebhardt
|Jun 28, 2023
Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies.Gabrielle Leclercq-Cohen, Nathalie Steinhoff, Llucia Albertí Servera
|Jun 13, 2022
Novel strategies for the mitigation of cytokine release syndrome induced by T cell engaging therapies with a focus on the use of kinase inhibitors.Gabrielle Leclercq, Nathalie Steinhoff, Hélène Haegel
|Feb 21, 2022
Dissecting the mechanism of cytokine release induced by T-cell engagers highlights the contribution of neutrophils.Gabrielle Leclercq, Llucia Alberti Servera, Sabrina Danilin
|Jan 22, 2022
JAK and mTOR inhibitors prevent cytokine release while retaining T cell bispecific antibody in vivo efficacy.Gabrielle Leclercq, Hélène Haegel, Alberto Toso
Pageof 2
Frequent Collaborators
6 joint publications
Christian Klein
3 joint publications
Marina Bacac
3 joint publications
Johannes Sam
3 joint publications
Sylvia Herter
2 joint publications
Alex Odermatt
2 joint publications
Llucia Alberti Servera
2 joint publications
Pablo Umaña
2 joint publications
Stephan Schmeing
2 joint publications
Emilio Yángüez
2 joint publications
Tamara Hüsser
